Recent News

By Category: Countermeasures

IAFC Testifies Before Congress on Medical Countermeasures

(FireEngineering.com) Today, Chief Al Gillespie, IAFC president and chairman of the board, testified before members of Congress urging the U.S. government to take action in including first responders and their families in medical countermeasures required in the event of a pandemic or biological attack. The hearings, held by the Subcommittee on Emergency Preparedness, Response and  Read More »

Webcast Hearing TODAY – Taking Measure of Countermeasures (Part 3): Protecting the Protectors

Washington, D.C. – The Homeland Security Subcommittee on Emergency Preparedness, Response, and Communications, chaired by Rep. Gus Bilirakis (R-FL), will hold a hearing entitled “Taking Measure of Countermeasures (Part 3): Protecting the Protectors” at 2 p.m. in Room 311 Cannon House Office Building. At tomorrow’s hearing, the Subcommittee will continue its examination of medical countermeasures for  Read More »

The Effect of Anti-lethal Toxin Antibodies on Anthrax Mortality

(Clinicians’ Biosecurity News) The traditional mortality from inhalational anthrax at the beginning of the 20th century was often reported as 90%, but it was 45% following the 2001 anthrax letter attacks. This marked reduction in mortality likely occurred because of improvements in the care of critically ill patients. That a high mortality rate persists despite  Read More »

Scientists warn of more disease outbreaks if vets’ labs are shut

(Yorkshire Post) A report by the Surveillance Advisory Group (SAG) into Defra’s plans to shake-up the way diseases such as foot-and-mouth are detected said that the current surveillance network needs to expand. Defra announced last year that the surveillance system, currently running at a cost of £10m per year would have to fall to £6m  Read More »

PharmAthene Presents Update on SparVax(TM) rPA Anthrax Vaccine Program

(Press Release) SparVax(TM) is being developed to meet the government’s need for an improved second generation anthrax vaccine that is safe, convenient, more cost-effective, and capable of providing rapid manufacturing scale-up in response to a national security emergency. New data based on a recent analysis of previous human clinical trial immunogenicity data and non-clinical animal  Read More »

« First...102030...9091929394...100110120...Last »

Also filed under "Countermeasures":